Does Insulin Resistance Deteriorate Brain Function?

Highlights

When the cells fail to respond to the hormone insulin due to fat surrounding the cells, it is called insulin resistance.
The resistance prevents muscle, fat, and liver cells from easily absorbing glucose and excess glucose is accumulated in the blood.
Apart from diabetes and certain hormone disturbances, insulin resistance is linked to cognitive impairment.

Insulin resistance, caused in part by obesity and physical inactivity, is also linked to a more rapid decline in cognitive performance.

According to the study published in the Journal of Alzheimer's Disease, both diabetic and non-diabetic subjects with insulin resistance experienced accelerated cognitive decline in executive function and memory.

Insulin - How it Works, Types, Administration, Precautions, Health Tips
Insulin is a natural hormone that controls our blood sugar. Learn about types of insulin and devices for delivery including insulin syringes, pens and insulin pumps.

‘Insulin resistance is related to subsequent poorer cognitive performance and greater cognitive decline among patients with cardiovascular disease with and without diabetes.’

Tweet it Now

The study was led jointly by Prof. David Tanne and Prof. Uri Goldbourt and conducted by Dr. Miri Lutski, all of TAU's Sackler School of Medicine.

Insulin Resistance

Insulin resistance is a condition in which cells fail to respond normally to the hormone insulin. The resistance prevents muscle, fat, and liver cells from easily absorbing glucose. As a result, the body requires higher levels of insulin to usher glucose into its cells.

Metabolic Syndrome - About
Metabolic Syndrome is associated with sedentary lifestyle .It makes a person more prone to develop type 2 diabetes and coronary artery disease.

Without sufficient insulin, excess glucose builds up in the bloodstream, leading to prediabetes, diabetes, and other serious health disorders.

Twenty-year Follow up study

Diabetes Type 2 and Its Link to Sugar-Sweetened Beverages
Sugar-sweetened beverages contribute to metabolic syndrome leading to higher risk for type-2 diabetes and cardiovascular disease.

The scientists followed a group of nearly 500 patients with existing cardiovascular disease for more than two decades. They first assessed the patients' baseline insulin resistance using the homeostasis model assessment (HOMA), calculated using fasting blood glucose and fasting insulin levels.

Cognitive functions were assessed with a computerized battery of tests that examined memory, executive function, visual spatial processing, and attention. The follow-up assessments were conducted 15 years after the start of the study, then again five years after that.

Fighting Diabesity with Lifestyle Changes
With more than one billion people affected, diabesity is the largest epidemic in the world today. Fortunately it can be reversed with lifestyle changes.

The study found that individuals placed in the top quarter of the HOMA index, were at an increased risk for poor cognitive performance and accelerated cognitive decline, compared to those in the remaining three-quarters of the HOMA index. Adjusting for established cardiovascular risk factors and potentially confounding factors did not diminish these associations.

"These are exciting findings because they may help to identify a group of individuals at increased risk of cognitive decline and dementia in older age," says Prof. Tanne. "We know that insulin resistance can be prevented and treated by lifestyle changes and certain insulin-sensitizing drugs.”

"This study lends support for more research to test the cognitive benefits of interventions such as exercise, diet, and medications that improve insulin resistance in order to prevent dementia," says Prof. Tanne. The team is currently studying the vascular and non-vascular mechanisms by which insulin resistance may affect cognition.

Reference

David Tanne et al., Insulin Resistance and Future Cognitive Performance and Cognitive Decline in Elderly Patients with Cardiovascular Disease, Journal of Alzheimer's Disease (2017) http://dx.doi.org/10.3233/JAD-161016.

Source-Medindia